Cargando…
IA期肺腺癌病理高危因素及术后辅助化疗研究进展
The survival rate needs to be improved in early stage non-small cell lung cancer patients. The risk of recurrence is relatively high in invasive adenocarcinoma patients with a solid or micropapillary component, lymphovascular invasion or tumor spread through air spaces. Systemic treatment options in...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411958/ https://www.ncbi.nlm.nih.gov/pubmed/36002196 http://dx.doi.org/10.3779/j.issn.1009-3419.2022.101.30 |